CPhI provides a networking platform for pharmaceutical industry leaders. As America accounts for approximately 40% of global pharmaceutical sales, CPhI North America is the ideal event that encourages pharmaceutical experts to interact with each other regarding innovation within the industry.
The 3-day, in-person, conference will touch on a broad horizon of relevant topics including market trends, ESG frameworks, pricing, integration of resources for small molecule transformation, cell & gene therapies and more.DDReg Business Development team shall be present in person at CPhI North America conference in Philadelphia from 17th-19th May and shall be meeting the pharma colleagues and business partners.
News
DDReg to participate in CPhI North America conference in Philadelphia from 17th-19th May, 2022

Published May 4, 2022By DDReg Regulatory Team
Share
Related Blogs

·2 min read
NewsDDReg Honored at ET Health Conclave 2025 for Excellence in Life Sciences Services
·2 min read
NewsDDReg in the News
·3 min read
NewsQuantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI
·3 min read
NewsManaging Director of DDReg chosen as finalist for CPhI Pharma Awards 2024
·1 min read
NewsDDReg Opens Entity in Singapore
·1 min read
NewsDDReg Opens German Entity in Cologne (Köln)
·4 min read
NewsDDReg Managing Director wins ET RE Pharma “Woman Icon of the Year” Award 2024
·2 min read
NewsDDReg Participates in India Pharma Awards 2023 for Excellence in Ancillary Pharma Services
·2 min read
NewsDDReg attends the OTC Health and Wellness Conference 2023
·1 min read
NewsDDReg nominated for India 5000 Best MSME Awards 2023
·1 min read
NewsDDReg Shortlisted for 'Regulatory' by CPHI Pharma Awards 2023
·1 min read
NewsDDReg receives the ISO 27001:2013 certification for Information Security Management System